About RPB
Research to Prevent Blindness (RPB) provides major eye research funding to 37 leading scientific institutions in the U.S. and supports the work of hundreds of talented vision scientists engaged in a diverse range of disease-oriented research.
RESEARCH TO PREVENT BLINDNESS EXPANDS GRANTS PROGRAM
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
Groundbreaking Gene Therapy for Retinal Disease
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
RPB and AAO Award Grants for Big Data Research to Advance Patient Care
Award recipients to use IRIS Registry database to conduct population-based studies.
Research to Prevent Blindness Expands Grants Program
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
Study Tests Stem Cell-based Therapy for Advanced Dry AMD
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
Study Links Aging Immune Cells and AMD
RPB-supported researchers at Washington University School of Medicine in St. Louis published the new findings.
The National Eye Institute Turns 50
RPB celebrates five decades of sight-saving discoveries at NEI.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
Our Partners
As a catalyst for vision research, Research to Prevent Blindness partners with other vision research funders-—combining resources, experience and capacity—to accelerate solutions for vision loss.
| General Info | Research Scientists & Grantees | Eye Care Specialists | Donors & Partners |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2018 Research to Prevent Blindness. All Rights Reserved.
